Clinical significance and correlation of microRNA-21 expression in patients undergoing transcatheter aortic valve replacement

Authors:

Abstract
A significant drop in circulating microRNA-21 levels 6 h after transcatheter aortic valve replacement (TAVR) was associated with a fourfold increased risk of major adverse cardiovascular or cerebrovascular events (MACCE). This prospective study identifies microRNA-21 as a promising early biomarker for risk stratification and prognosis after TAVR, offering potential for more personalized postprocedural care.

This publication has 25 references indexed in Scilit: